TFX

Teleflex Incorporated

NYSEHealthcareMedical - Instruments & SuppliesUS

Rating:C+

Company Profile

CEO

Stuart A. Randle

IPO Date

1980-03-17

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NYSE

Country

News SentimentNeutral

Articles

Avg Positive

24.9%

Avg Negative

28.6%

Avg Neutral

46.4%

News Feed

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

businesswire.com·5/21/2026·↑ positive

TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash

zacks.com·5/13/2026·↓ negative